Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.

Dominik Andreas BarthJ M RiedlF PoschM A SmolleA-K KasparekT NiedristJ SzkanderaH StögerM PichlerM StotzA Gerger

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)

Small platelets are not predicting CRC outcomes, and thus are hardly useful for influencing clinical decision making.

Keyphrases

decision making
type diabetes
adipose tissue
skeletal muscle
insulin resistance
red blood cell
smoking cessation